Immatics Events Q4 2018

| News

Immatics, a leading company in the field of cancer immunotherapy, will be attending the industry conferences and meetings listed below. You can also download the complete list here: Immatics Events Q4 2018. 

To arrange meetings with Immatics at any of the events, please contact


FDA/CDER-HESI Workshop on Preclinical and Translational Safety Assessment of CD3 Bispecifics

October 1st-2nd, Silver Spring, Maryland, USA


ESMO Congress 2018

October 19th-23rd, Munich, Germany


Strategic and Operational Challenges of Oncology&IO Drug Development

October 25th-26th, Philadelphia, USA


European Antibody Congress 

October 29th-31st, Basel, Switzerland


World Immunotherapy Congress 2018

October 29th-31st, Basel, Switzerland


5th USP Workshop on Therapeutic Peptides

November 5th-6th, Rockville, Maryland, USA


Bio Europe 2018

November 5th-7th, Copenhagen, Denmark


SITC 2018

November 7th-11th, Washington, USA


Texas Life Science Forum

November 8th, Houston, USA


Protein & Antibody Engineering Summit, PEGS Europe

November 12th-16th, Lisbon, Portugal


60th ASH Annual Meeting & Exposition

December 1st-4th, San Diego, USA


Cell Therapy Manufacturing & Gene Therapy Congress

December 4th-5th, Amsterdam, Netherlands


Antibody Engineering & Therapeutics

December 9th-13th, San Diego, USA


Press Contact

Anja Heuer

Corporate Communications,
Immatics Biotechnologies GmbH

+49 89 540 415 606

Go back

We use cookies to ensure that we give you the best experience on our website.